About
Minkyu Jung is a medical oncologist for stomach and melanoma cancer patients. He has worked as a principal investigator and sub-investigator, form fist in human study to large phase III trials for 15 years. He has also worked on translational research about resistance of targeted and immunotherapy including chimeric antigen receptor T cell using organoid and xenograft model. In addition, he is a chief of Palliative Care Center at Yonsei Cancer Center since 2019.
Other Appointments
- Administrative staff, Gastric Cancer Committee of Korean Cancer Study Group (KCSG)
- Active member, Korean Cancer Association (KCA)
- Active member, Korean Society of Medical Oncology (KSMO)
- Active member, American Society of Clinical Oncology (ASCO)
- Active member, European Society of Medical Oncology (ESMO)
Key Accomplishments
- Associated editor, Yonsei Medical Journal, since 2020
- Reviewer, Korean Journal of Medicine, since 2014
Education / Honors
- Excellence in Research Award form Roche and KCA, 2020
- Visiting scholar, Weill Cornell Medicine, 2017-2019
- Young Investigator Research Award, Boryung and KSMO, 2017
- Ph.D., Yonsei University College of Medicine, 2017
- Excellence in Research Award, Merck-Serono and KSMO, 2013
- Excellent Graduate Student, KCA, 2009
- M.S., Yonsei University College of Medicine, 2008
- Fellow, Yonsei Cancer Center, 2009-2010
- Resident, Department of Internal Medicine, 2005-2009
- Internship, Severance Hospital, 2004
- M.D., Yonsei University College of Medicine, 2003
- Best Student Award, Yonsei University, 1999
- B. A., Department of Biology, Yonsei University, 1999
Please Leave a Review or Suggestion